Resolves YES if China approves a COVID vaccine based on mRNA technology by the end of 2023. Resolves NO if not.
Related questions
🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ529 | |
| 2 | Ṁ379 | |
| 3 | Ṁ278 | |
| 4 | Ṁ53 | |
| 5 | Ṁ47 |
@BTE Is there a reason this hasn't already resolved positively, given the the CPSC vaccine was approved in March?
This sounds like this market is to low, atleast slightly
in any case, this should happen this year with the CanSino's vaccine: https://www.wsj.com/articles/china-developed-mrna-covid-vaccine-starts-test-production-11673001366?st=na769jqmqbscvtm&reflink=desktopwebshare_permalink
@egroj Yes, it appears China has a program similar to the US Emergency Use Authorization so basically everything related to covid has limited approval only.
@BTE how about for foreign residents? It seems that might happen soon with BioNTech's vaccine https://www.wsj.com/articles/china-agrees-to-approve-biontech-s-covid-19-vaccines-for-foreigners-german-chancellor-says-11667556193?st=spaqmy5i7iztoum&reflink=desktopwebshare_permalink
@egroj Sorry I missed this. No this does not count. General approval for Chinese. This is essentially an exemption for Germans.
